This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Preterm Labor or Fetal Glucocorticoid Exposure
and you are
The phase for this study is not defined.
Show me locations

The purpose

Administration of corticosteroids is standard practice for pregnant patients at risk of preterm labour to reduce the risk of neonatal respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis and neonatal mortality. However, there is an unknown effect of antenatal steroids on both fetal and neonatal immune function. The purpose of this study is to demonstrate the effect of antenatal steroids on the size of the fetal thymus gland.

Provided treatments

  • Other: 2D ultrasound assessment
Tris trial is registered with FDA with number: NCT03057717. The sponsor of the trial is St. Michael's Hospital, Toronto and it is looking for 86 volunteers for the current phase.
Official trial title:
The Effect of Antenatal Corticosteroids on the Fetal Thymus - a Possible Role in Fetal Immune